aluates Reports

$ 0.0

Automative

Global Infectious Disease Diagnostics Testing Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Othe-2O272

Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Infectious Disease Diagnostics Testing Market Insights, Forecast to 2029

Code: QYRE-Othe-2O272

Report

August 2023

Pages:116

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

bioMérieux

Roche Diagnostic

Beckman Coulter

Becton Dickinson and Company

Bio Rad Laboratories

Cavidi

Corgenix

Diaxonhit

Eiken Chemical

EMD Millipore

Epitope Diagnostic

EUROIMMUN

Gold Standard Diagnostics

Hologic Inc

Immunetics

InBios International

Abbott

Cepheid Inc

DiaSorin

Infectious Disease Diagnostics Testing Market Size

The global Infectious Disease Diagnostics Testing market is projected to grow from US$ 17160 million in 2023 to US$ 21090 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.

Infectious Disease Diagnostics Testing Market

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.

Market Analysis and Insights: Global Infectious Disease Diagnostics Testing Market

Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.

Report Includes

This report presents an overview of global market for Infectious Disease Diagnostics Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Infectious Disease Diagnostics Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Infectious Disease Diagnostics Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Infectious Disease Diagnostics Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Infectious Disease Diagnostics Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Infectious Disease Diagnostics Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Cavidi and Cepheid, etc.

Scope of Infectious Disease Diagnostics Testing Market Report

Report Metric	Details
Report Name	Infectious Disease Diagnostics Testing Market
Accounted market size in 2023	US$ 17160 million
Forecasted market size in 2029	US$ 21090 million
CAGR	3.5
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Molecular Diagnostic Test POC Infectious Disease Diagnostics Test
Segment by Application	Hospital Academics Research Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Infectious Disease Diagnostics Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Diagnostics Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infectious Disease Diagnostics Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Infectious Disease Diagnostics Testing Market growing?

Ans: The Infectious Disease Diagnostics Testing Market witnessing a CAGR of 3.5 during the forecast period 2023-2029.

What is the Infectious Disease Diagnostics Testing Market size in 2029?

Ans: The global Infectious Disease Diagnostics Testing market is projected to grow from US$ 17160 million in 2023 to US$ 21090 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.

Who are the main players in the Infectious Disease Diagnostics Testing Market report?

Ans: The main players in the Infectious Disease Diagnostics Testing Market are Abbott, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International

What are the Application segmentation covered in the Infectious Disease Diagnostics Testing Market report?

Ans: The Applications covered in the Infectious Disease Diagnostics Testing Market report are Hospital, Academics Research, Others

What are the Type segmentation covered in the Infectious Disease Diagnostics Testing Market report?

Ans: The Types covered in the Infectious Disease Diagnostics Testing Market report are Molecular Diagnostic Test, POC Infectious Disease Diagnostics Test

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Molecular Diagnostic Test

1.2.3 POC Infectious Disease Diagnostics Test

1.3 Market by Application

1.3.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Academics Research

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Disease Diagnostics Testing Market Perspective (2018-2029)

2.2 Global Infectious Disease Diagnostics Testing Growth Trends by Region

2.2.1 Infectious Disease Diagnostics Testing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Infectious Disease Diagnostics Testing Historic Market Size by Region (2018-2023)

2.2.3 Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2024-2029)

2.3 Infectious Disease Diagnostics Testing Market Dynamics

2.3.1 Infectious Disease Diagnostics Testing Industry Trends

2.3.2 Infectious Disease Diagnostics Testing Market Drivers

2.3.3 Infectious Disease Diagnostics Testing Market Challenges

2.3.4 Infectious Disease Diagnostics Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Infectious Disease Diagnostics Testing by Players

3.1.1 Global Infectious Disease Diagnostics Testing Revenue by Players (2018-2023)

3.1.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Players (2018-2023)

3.2 Global Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Infectious Disease Diagnostics Testing, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Infectious Disease Diagnostics Testing Market Concentration Ratio

3.4.1 Global Infectious Disease Diagnostics Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostics Testing Revenue in 2022

3.5 Global Key Players of Infectious Disease Diagnostics Testing Head office and Area Served

3.6 Global Key Players of Infectious Disease Diagnostics Testing, Product and Application

3.7 Global Key Players of Infectious Disease Diagnostics Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Diagnostics Testing Breakdown Data by Type

4.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Type (2018-2023)

4.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2024-2029)

5 Infectious Disease Diagnostics Testing Breakdown Data by Application

5.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Application (2018-2023)

5.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Infectious Disease Diagnostics Testing Market Size (2018-2029)

6.2 North America Infectious Disease Diagnostics Testing Market Size by Type

6.2.1 North America Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)

6.2.2 North America Infectious Disease Diagnostics Testing Market Size by Type (2024-2029)

6.2.3 North America Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

6.3 North America Infectious Disease Diagnostics Testing Market Size by Application

6.3.1 North America Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)

6.3.2 North America Infectious Disease Diagnostics Testing Market Size by Application (2024-2029)

6.3.3 North America Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

6.4 North America Infectious Disease Diagnostics Testing Market Size by Country

6.4.1 North America Infectious Disease Diagnostics Testing Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023)

6.4.3 North America Infectious Disease Diagnostics Testing Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Infectious Disease Diagnostics Testing Market Size (2018-2029)

7.2 Europe Infectious Disease Diagnostics Testing Market Size by Type

7.2.1 Europe Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)

7.2.2 Europe Infectious Disease Diagnostics Testing Market Size by Type (2024-2029)

7.2.3 Europe Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

7.3 Europe Infectious Disease Diagnostics Testing Market Size by Application

7.3.1 Europe Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)

7.3.2 Europe Infectious Disease Diagnostics Testing Market Size by Application (2024-2029)

7.3.3 Europe Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

7.4 Europe Infectious Disease Diagnostics Testing Market Size by Country

7.4.1 Europe Infectious Disease Diagnostics Testing Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Infectious Disease Diagnostics Testing Market Size by Country (2018-2023)

7.4.3 Europe Infectious Disease Diagnostics Testing Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Infectious Disease Diagnostics Testing Market Size (2018-2029)

8.2 China Infectious Disease Diagnostics Testing Market Size by Type

8.2.1 China Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)

8.2.2 China Infectious Disease Diagnostics Testing Market Size by Type (2024-2029)

8.2.3 China Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

8.3 China Infectious Disease Diagnostics Testing Market Size by Application

8.3.1 China Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)

8.3.2 China Infectious Disease Diagnostics Testing Market Size by Application (2024-2029)

8.3.3 China Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Infectious Disease Diagnostics Testing Market Size (2018-2029)

9.2 Asia Infectious Disease Diagnostics Testing Market Size by Type

9.2.1 Asia Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)

9.2.2 Asia Infectious Disease Diagnostics Testing Market Size by Type (2024-2029)

9.2.3 Asia Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

9.3 Asia Infectious Disease Diagnostics Testing Market Size by Application

9.3.1 Asia Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)

9.3.2 Asia Infectious Disease Diagnostics Testing Market Size by Application (2024-2029)

9.3.3 Asia Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

9.4 Asia Infectious Disease Diagnostics Testing Market Size by Region

9.4.1 Asia Infectious Disease Diagnostics Testing Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Infectious Disease Diagnostics Testing Market Size by Region (2018-2023)

9.4.3 Asia Infectious Disease Diagnostics Testing Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type

10.2.1 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application

10.3.1 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country

10.4.1 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Infectious Disease Diagnostics Testing Introduction

11.1.4 Abbott Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.1.5 Abbott Recent Developments

11.2 bioMérieux

11.2.1 bioMérieux Company Details

11.2.2 bioMérieux Business Overview

11.2.3 bioMérieux Infectious Disease Diagnostics Testing Introduction

11.2.4 bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.2.5 bioMérieux Recent Developments

11.3 Diasorin

11.3.1 Diasorin Company Details

11.3.2 Diasorin Business Overview

11.3.3 Diasorin Infectious Disease Diagnostics Testing Introduction

11.3.4 Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.3.5 Diasorin Recent Developments

11.4 Roche Diagnostic

11.4.1 Roche Diagnostic Company Details

11.4.2 Roche Diagnostic Business Overview

11.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Introduction

11.4.4 Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.4.5 Roche Diagnostic Recent Developments

11.5 Beckman Coulter

11.5.1 Beckman Coulter Company Details

11.5.2 Beckman Coulter Business Overview

11.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Introduction

11.5.4 Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.5.5 Beckman Coulter Recent Developments

11.6 Becton, Dickinson and Company

11.6.1 Becton, Dickinson and Company Company Details

11.6.2 Becton, Dickinson and Company Business Overview

11.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Introduction

11.6.4 Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.6.5 Becton, Dickinson and Company Recent Developments

11.7 Bio-Rad Laboratories

11.7.1 Bio-Rad Laboratories Company Details

11.7.2 Bio-Rad Laboratories Business Overview

11.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Introduction

11.7.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.7.5 Bio-Rad Laboratories Recent Developments

11.8 Cavidi

11.8.1 Cavidi Company Details

11.8.2 Cavidi Business Overview

11.8.3 Cavidi Infectious Disease Diagnostics Testing Introduction

11.8.4 Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.8.5 Cavidi Recent Developments

11.9 Cepheid

11.9.1 Cepheid Company Details

11.9.2 Cepheid Business Overview

11.9.3 Cepheid Infectious Disease Diagnostics Testing Introduction

11.9.4 Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.9.5 Cepheid Recent Developments

11.10 Corgenix

11.10.1 Corgenix Company Details

11.10.2 Corgenix Business Overview

11.10.3 Corgenix Infectious Disease Diagnostics Testing Introduction

11.10.4 Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.10.5 Corgenix Recent Developments

11.11 Diaxonhit

11.11.1 Diaxonhit Company Details

11.11.2 Diaxonhit Business Overview

11.11.3 Diaxonhit Infectious Disease Diagnostics Testing Introduction

11.11.4 Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.11.5 Diaxonhit Recent Developments

11.12 Eiken Chemical

11.12.1 Eiken Chemical Company Details

11.12.2 Eiken Chemical Business Overview

11.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Introduction

11.12.4 Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.12.5 Eiken Chemical Recent Developments

11.13 EMD Millipore

11.13.1 EMD Millipore Company Details

11.13.2 EMD Millipore Business Overview

11.13.3 EMD Millipore Infectious Disease Diagnostics Testing Introduction

11.13.4 EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.13.5 EMD Millipore Recent Developments

11.14 Epitope Diagnostic

11.14.1 Epitope Diagnostic Company Details

11.14.2 Epitope Diagnostic Business Overview

11.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Introduction

11.14.4 Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.14.5 Epitope Diagnostic Recent Developments

11.15 EUROIMMUN

11.15.1 EUROIMMUN Company Details

11.15.2 EUROIMMUN Business Overview

11.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Introduction

11.15.4 EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.15.5 EUROIMMUN Recent Developments

11.16 Gold Standard Diagnostics

11.16.1 Gold Standard Diagnostics Company Details

11.16.2 Gold Standard Diagnostics Business Overview

11.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Introduction

11.16.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.16.5 Gold Standard Diagnostics Recent Developments

11.17 Hologic

11.17.1 Hologic Company Details

11.17.2 Hologic Business Overview

11.17.3 Hologic Infectious Disease Diagnostics Testing Introduction

11.17.4 Hologic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.17.5 Hologic Recent Developments

11.18 Immunetics

11.18.1 Immunetics Company Details

11.18.2 Immunetics Business Overview

11.18.3 Immunetics Infectious Disease Diagnostics Testing Introduction

11.18.4 Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.18.5 Immunetics Recent Developments

11.19 InBios International

11.19.1 InBios International Company Details

11.19.2 InBios International Business Overview

11.19.3 InBios International Infectious Disease Diagnostics Testing Introduction

11.19.4 InBios International Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)

11.19.5 InBios International Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

bioMérieux

Roche Diagnostic

Beckman Coulter

Becton Dickinson and Company

Bio Rad Laboratories

Cavidi

Corgenix

Diaxonhit

Eiken Chemical

EMD Millipore

Epitope Diagnostic

EUROIMMUN

Gold Standard Diagnostics

Hologic Inc

Immunetics

InBios International

Abbott

Cepheid Inc

DiaSorin

List of Tables

Table 1. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Molecular Diagnostic Test

Table 3. Key Players of POC Infectious Disease Diagnostics Test

Table 4. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Infectious Disease Diagnostics Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Infectious Disease Diagnostics Testing Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Infectious Disease Diagnostics Testing Market Share by Region (2018-2023)

Table 8. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Infectious Disease Diagnostics Testing Market Share by Region (2024-2029)

Table 10. Infectious Disease Diagnostics Testing Market Trends

Table 11. Infectious Disease Diagnostics Testing Market Drivers

Table 12. Infectious Disease Diagnostics Testing Market Challenges

Table 13. Infectious Disease Diagnostics Testing Market Restraints

Table 14. Global Infectious Disease Diagnostics Testing Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Infectious Disease Diagnostics Testing Revenue Share by Players (2018-2023)

Table 16. Global Top Infectious Disease Diagnostics Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2022)

Table 17. Global Infectious Disease Diagnostics Testing Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Infectious Disease Diagnostics Testing Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Infectious Disease Diagnostics Testing, Headquarters and Area Served

Table 20. Global Key Players of Infectious Disease Diagnostics Testing, Product and Application

Table 21. Global Key Players of Infectious Disease Diagnostics Testing, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2018-2023)

Table 25. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2024-2029)

Table 27. Global Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Infectious Disease Diagnostics Testing Revenue Share by Application (2018-2023)

Table 29. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Infectious Disease Diagnostics Testing Revenue Share by Application (2024-2029)

Table 31. North America Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Infectious Disease Diagnostics Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Infectious Disease Diagnostics Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Infectious Disease Diagnostics Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Infectious Disease Diagnostics Testing Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Infectious Disease Diagnostics Testing Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)

Table 63. Abbott Company Details

Table 64. Abbott Business Overview

Table 65. Abbott Infectious Disease Diagnostics Testing Product

Table 66. Abbott Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 67. Abbott Recent Developments

Table 68. bioMérieux Company Details

Table 69. bioMérieux Business Overview

Table 70. bioMérieux Infectious Disease Diagnostics Testing Product

Table 71. bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 72. bioMérieux Recent Developments

Table 73. Diasorin Company Details

Table 74. Diasorin Business Overview

Table 75. Diasorin Infectious Disease Diagnostics Testing Product

Table 76. Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 77. Diasorin Recent Developments

Table 78. Roche Diagnostic Company Details

Table 79. Roche Diagnostic Business Overview

Table 80. Roche Diagnostic Infectious Disease Diagnostics Testing Product

Table 81. Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 82. Roche Diagnostic Recent Developments

Table 83. Beckman Coulter Company Details

Table 84. Beckman Coulter Business Overview

Table 85. Beckman Coulter Infectious Disease Diagnostics Testing Product

Table 86. Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 87. Beckman Coulter Recent Developments

Table 88. Becton, Dickinson and Company Company Details

Table 89. Becton, Dickinson and Company Business Overview

Table 90. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product

Table 91. Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 92. Becton, Dickinson and Company Recent Developments

Table 93. Bio-Rad Laboratories Company Details

Table 94. Bio-Rad Laboratories Business Overview

Table 95. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product

Table 96. Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 97. Bio-Rad Laboratories Recent Developments

Table 98. Cavidi Company Details

Table 99. Cavidi Business Overview

Table 100. Cavidi Infectious Disease Diagnostics Testing Product

Table 101. Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 102. Cavidi Recent Developments

Table 103. Cepheid Company Details

Table 104. Cepheid Business Overview

Table 105. Cepheid Infectious Disease Diagnostics Testing Product

Table 106. Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 107. Cepheid Recent Developments

Table 108. Corgenix Company Details

Table 109. Corgenix Business Overview

Table 110. Corgenix Infectious Disease Diagnostics Testing Product

Table 111. Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 112. Corgenix Recent Developments

Table 113. Diaxonhit Company Details

Table 114. Diaxonhit Business Overview

Table 115. Diaxonhit Infectious Disease Diagnostics Testing Product

Table 116. Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 117. Diaxonhit Recent Developments

Table 118. Eiken Chemical Company Details

Table 119. Eiken Chemical Business Overview

Table 120. Eiken Chemical Infectious Disease Diagnostics Testing Product

Table 121. Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 122. Eiken Chemical Recent Developments

Table 123. EMD Millipore Company Details

Table 124. EMD Millipore Business Overview

Table 125. EMD Millipore Infectious Disease Diagnostics Testing Product

Table 126. EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 127. EMD Millipore Recent Developments

Table 128. Epitope Diagnostic Company Details

Table 129. Epitope Diagnostic Business Overview

Table 130. Epitope Diagnostic Infectious Disease Diagnostics Testing Product

Table 131. Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 132. Epitope Diagnostic Recent Developments

Table 133. EUROIMMUN Company Details

Table 134. EUROIMMUN Business Overview

Table 135. EUROIMMUN Infectious Disease Diagnostics Testing Product

Table 136. EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 137. EUROIMMUN Recent Developments

Table 138. Gold Standard Diagnostics Company Details

Table 139. Gold Standard Diagnostics Business Overview

Table 140. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product

Table 141. Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 142. Gold Standard Diagnostics Recent Developments

Table 143. Hologic Company Details

Table 144. Hologic Business Overview

Table 145. Hologic Infectious Disease Diagnostics Testing Product

Table 146. Hologic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 147. Hologic Recent Developments

Table 148. Immunetics Company Details

Table 149. Immunetics Business Overview

Table 150. Immunetics Infectious Disease Diagnostics Testing Product

Table 151. Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 152. Immunetics Recent Developments

Table 153. InBios International Company Details

Table 154. InBios International Business Overview

Table 155. InBios International Infectious Disease Diagnostics Testing Product

Table 156. InBios International Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)

Table 157. InBios International Recent Developments

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Infectious Disease Diagnostics Testing Market Share by Type: 2022 VS 2029

Figure 3. Molecular Diagnostic Test Features

Figure 4. POC Infectious Disease Diagnostics Test Features

Figure 5. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Infectious Disease Diagnostics Testing Market Share by Application: 2022 VS 2029

Figure 7. Hospital Case Studies

Figure 8. Academics Research Case Studies

Figure 9. Others Case Studies

Figure 10. Infectious Disease Diagnostics Testing Report Years Considered

Figure 11. Global Infectious Disease Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Infectious Disease Diagnostics Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Infectious Disease Diagnostics Testing Market Share by Region: 2022 VS 2029

Figure 14. Global Infectious Disease Diagnostics Testing Market Share by Players in 2022

Figure 15. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Infectious Disease Diagnostics Testing Revenue in 2022

Figure 17. North America Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

Figure 19. North America Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

Figure 20. North America Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)

Figure 21. United States Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Infectious Disease Diagnostics Testing Market Size YoY (2018-2029) & (US$ Million)

Figure 24. Europe Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

Figure 25. Europe Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

Figure 26. Europe Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)

Figure 27. Germany Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. France Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. U.K. Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Italy Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Russia Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Nordic Countries Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. China Infectious Disease Diagnostics Testing Market Size YoY (2018-2029) & (US$ Million)

Figure 34. China Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

Figure 35. China Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

Figure 36. Asia Infectious Disease Diagnostics Testing Market Size YoY (2018-2029) & (US$ Million)

Figure 37. Asia Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

Figure 38. Asia Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

Figure 39. Asia Infectious Disease Diagnostics Testing Market Share by Region (2018-2029)

Figure 40. Japan Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. South Korea Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. China Taiwan Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. India Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Australia Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size YoY (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)

Figure 48. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)

Figure 49. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)

Figure 50. Brazil Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Mexico Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Turkey Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Israel Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. GCC Countries Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Abbott Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 57. bioMérieux Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 58. Diasorin Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 59. Roche Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 60. Beckman Coulter Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 61. Becton, Dickinson and Company Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 63. Cavidi Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 64. Cepheid Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 65. Corgenix Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 66. Diaxonhit Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 67. Eiken Chemical Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 68. EMD Millipore Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 69. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 70. EUROIMMUN Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 71. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 72. Hologic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 73. Immunetics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 74. InBios International Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions